Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07591649
What this trial is testing

Adapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT

Who this might be right for
Relapsed Adult AMLRefractory AMLAcute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 18
Not applicableStudy completedNCT04788420
What this trial is testing

Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With FLT3/ITD MutationHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 456
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07449286
What this trial is testing

IFN-α in Relapse Prevention.

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 100
Testing effectiveness (Phase 2)UnknownNCT06468267
What this trial is testing

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Xianmin Song, MD 50
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Large-scale testing (Phase 3)UnknownNCT04098653
What this trial is testing

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationConditioningMyeloid Tumors
Nanfang Hospital, Southern Medical University 196
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07091006
What this trial is testing

Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML

Who this might be right for
Relapse Leukemia
Ruijin Hospital 44
Not applicableNot Yet RecruitingNCT06385808
What this trial is testing

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

Who this might be right for
Relapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more
First Affiliated Hospital Xi'an Jiaotong University 37
Testing effectiveness (Phase 2)UnknownNCT05559450
What this trial is testing

Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 80
Testing effectiveness (Phase 2)Ended earlyNCT06102213
What this trial is testing

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematologic Malignancy
Prolacta Bioscience 46
Large-scale testing (Phase 3)Study completedNCT02670252
What this trial is testing

BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationBusulfanTotal Body Irradiation+1 more
Nanfang Hospital, Southern Medical University 550
Not applicableNot Yet RecruitingNCT07635485
What this trial is testing

VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML

Who this might be right for
Hypoplastic Acute Myeloid LeukemiaSecondary AML (Adult)
The First Affiliated Hospital of Soochow University 50
Not applicableNot Yet RecruitingNCT07581093
What this trial is testing

The REACT Study: REhabilitation and ACTivity in Allogenic Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
University of Dublin, Trinity College 140
Large-scale testing (Phase 3)UnknownNCT03256071
What this trial is testing

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning
The First Affiliated Hospital of Soochow University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06438796
What this trial is testing

Blinatumomab Maintenance After Allo-HSCT

Who this might be right for
High Risk Acute Lymphoblastic Leukemia
Ruijin Hospital 59
Testing effectiveness (Phase 2)UnknownNCT05084027
What this trial is testing

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Who this might be right for
Hematologic MalignancyOlder PatientsAllogeneic Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University 50
Not applicableUnknownNCT05675826
What this trial is testing

The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Who this might be right for
COVID-19Hematopoietic Stem Cell Transplantation
Chen Suning 40
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Not applicableStudy completedNCT06198517
What this trial is testing

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang 303
Not applicableNot Yet RecruitingNCT07666568
What this trial is testing

Younger vs. Older Donors in Allo-HSCT: TTE

Who this might be right for
A Target Trial Emulation StudyDonor AgeALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University 5,000
Next Page